Percutaneous Coronary Intervention Completed Phase 3 Trials for Phylloquinone (DB01022)

Also known as: Percutaneous Coronary Intervention (PCI) / PCI / Percutaneous coronary intervention (procedure)

IndicationStatusPhase
DBCOND0030679 (Percutaneous Coronary Intervention)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01830543A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary InterventionTreatment